Use of artificial intelligence in evidence synthesis for EASD guidelines: an EASD Guidelines Oversight Committee statement

The aim of this EASD Guidelines Oversight Committee statement is to provide a framework for the responsible use of artificial intelligence (AI) tools in evidence syntheses supporting EASD clinical practice guidelines. The statement builds on the EASD Standard Operating Procedure for guideline development. It supports and operationalises the Responsible use of AI in Evidence Synthesis (RAISE) guidance within the framework of the Guidelines International Network (GIN) principles. The statement sets out EASD requirements for AI use in evidence synthesis, covering transparency, preplanning, additionality, credibility, ethics, accountability, compliance and evaluation. It also describes implementation steps within the EASD guideline process, including consideration of AI use, specification in evidence synthesis protocols, evaluation and approval, review-specific pilot testing, implementation oversight, and reporting. As such, it provides practical guidance on how AI can be responsibly incorporated into evidence syntheses for EASD guidelines, supporting transparent, validation-informed and human-supervised AI use.

Authors

Institutions

Publication Details

Journal
Diabetologia
Published
2026-11-17
DOI
https://doi.org/10.1007/s00125-026-06912-1
Primary Topic
Clinical practice guidelines implementation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Use of artificial intelligence in evidence synthesis for EASD guidelines: an EASD Guidelines Oversight Committee statement

Dı́dac Mauricio, Απόστολος Τσάπας, Richard I. G. Holt, Stefano Del Prato et al.
Diabetologia
Clinical practice guidelines implementation
article

Use of artificial intelligence in evidence synthesis for EASD guidelines: an EASD Guidelines Oversight Committee statement

Dı́dac Mauricio, Απόστολος Τσάπας, Richard I. G. Holt, Stefano Del Prato, Valentina Lorenzoni, Ioannis Avgerinos, Seán F. Dinneen, Ádám Hulmán, Chantal Mathieu, Ludovico Di Gioia, Tsvetalina I. Tankova, Francesco Giorgino, Oliver Kuß, Francesco Zaccardi, Thomas Karagiannis, Melanie Jane Davies
article en

Abstract

The aim of this EASD Guidelines Oversight Committee statement is to provide a framework for the responsible use of artificial intelligence (AI) tools in evidence syntheses supporting EASD clinical practice guidelines. The statement builds on the EASD Standard Operating Procedure for guideline development. It supports and operationalises the Responsible use of AI in Evidence Synthesis (RAISE) guidance within the framework of the Guidelines International Network (GIN) principles. The statement sets out EASD requirements for AI use in evidence synthesis, covering transparency, preplanning, additionality, credibility, ethics, accountability, compliance and evaluation. It also describes implementation steps within the EASD guideline process, including consideration of AI use, specification in evidence synthesis protocols, evaluation and approval, review-specific pilot testing, implementation oversight, and reporting. As such, it provides practical guidance on how AI can be responsibly incorporated into evidence syntheses for EASD guidelines, supporting transparent, validation-informed and human-supervised AI use.

Diabetologia
University of Leicester (GB), Scuola Superiore Sant'Anna (IT), Ollscoil na Gaillimhe – University of Galway (IE), Aarhus University (DK), Aristotle University of Thessaloniki (GR), Universitair Ziekenhuis Leuven (BE), Hospital de Sant Pau (ES), Aarhus University Hospital (DK), University Hospital Galway (IE), University Hospital Southampton NHS Foundation Trust (GB), Medical University of Sofia (BG), National Institute for Health and Care Research (GB), Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES), Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT), Ospedale Generale Regionale Francesco Miulli (IT), Deutsches Diabetes-Zentrum e.V. (DE), NIHR Leicester Biomedical Research Centre (GB), University of Southampton (GB), Institut de Recerca Sant Pau (ES), Steno Diabetes Center Aarhus (DK), Heinrich Heine University Düsseldorf (DE), University of Bari Aldo Moro (IT), KU Leuven (BE)
Clinical practice guidelines implementation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon